Research Progress on the Cardiovascular Protective Effect of Glucagon-Like Peptide-1 Receptor Agonists

The risk of cardiovascular diseases is closely related to diabetes. Macrovascular disease is the main cause of death and disability in patients with type 2 diabetes. In recent years, the glucagon-like peptide-1 receptor agonist (GLP-1RA), a new type of hypoglycemic drug, has been shown to regulate b...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Rui, Qian, Hang, Wang, Yunlian, Li, Qingmei, Li, Dongfeng, Chen, Jishun, Yang, Jingning, Zhong, Jixin, Yang, Handong, Min, Xinwen, Xu, Hao, Yang, Yong, Chen, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012640/
https://www.ncbi.nlm.nih.gov/pubmed/35434139
http://dx.doi.org/10.1155/2022/4554996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012640/
https://www.ncbi.nlm.nih.gov/pubmed/35434139
http://dx.doi.org/10.1155/2022/4554996

Ejemplares similares